Global Medical Tech Becton, Dickinson Expects Lower China Sales, Bioscience And Pharma Market Dynamics To Impact 2025 Organic Revenue Growth

By Yahoo! Finance | Nov 7, 2024 at 01:28 PM EST

Becton, Dickinson and Company reported strong fourth-quarter sales, exceeding expectations. The company is focusing on higher-growth areas and innovation to enhance patient care. BD projects growth and increased dividends for FY25 despite challenges in China and the Pharma market.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.